Bixiye
P28-21 Updated Prior Authorization Requirements for Psychological and Neuropsychological Testing for Commercial and Medicare Advantage Products
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1691 - 1700 ee natiijooyinka 3613
Bixiye
2021 May Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P31-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P30-21 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P24-21 2021 Renewal Changes Summary for Aware Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P25-21 2021 Renewal Changes Summary for Suppliers of Durable Medical Equipment
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P23-21 2021 Renewal Changes Summary for Blue Plus Referral Health Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
Inhaled Antibiotics Duplicate Therapy - Commercial - Effective Date 03/01/2025
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025
Bixiye
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) - Medicaid - Effective Date 03/01/2025
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2025
Bixiye
ATTR Amyloidosis - Medicaid
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025